Poseida Therapeutics, Inc.
PSTX · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $20,235 | -$31,371 | -$24,274 | -$25,349 |
| Dep. & Amort. | $1,319 | $1,349 | $1,380 | $1,438 |
| Deferred Tax | $0 | $0 | $0 | $3,989 |
| Stock-Based Comp. | $4,959 | $7,629 | $5,383 | $5,063 |
| Change in WC | -$66,206 | $62,203 | $4,003 | -$7,962 |
| Other Non-Cash | $30,099 | $9,081 | $10,095 | $5,607 |
| Operating Cash Flow | -$9,594 | $38,450 | -$15,135 | -$28,744 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$645 | -$1,019 | -$130 | -$309 |
| Net Acquisitions | $0 | $0 | $0 | $40,626 |
| Inv. Purchases | -$31,708 | -$102,683 | -$53,367 | -$21,978 |
| Inv. Sales/Matur. | $60,000 | $42,500 | $77,500 | $70,000 |
| Other Inv. Act. | $0 | -$60,183 | $24,133 | $48,022 |
| Investing Cash Flow | $27,647 | -$61,202 | $24,003 | $47,713 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | -$549 | $0 | $549 | -$14,069 |
| Stock Repurch. | $592 | $0 | -$592 | $494 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $742 | $0 | -$43 | $13,575 |
| Financing Cash Flow | $742 | $0 | -$43 | $94,817 |
| Forex Effect | $0 | $0 | $0 | -$94,817 |
| Net Chg. in Cash | $18,795 | -$22,752 | $8,825 | $18,969 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $30,545 | $53,297 | $44,472 | $25,503 |
| End Cash | $49,340 | $30,545 | $53,297 | $44,472 |
| Free Cash Flow | -$10,239 | $37,431 | -$15,265 | -$29,053 |